Security key
G6674U108
NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)
CUSIP: G6674U108
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Ordinary Shares, no par value per share
- Total 13F shares
- 25,018
- Total 13F value
- $399,039
- Share change
- +9,860
- SEC-reported price per share
- $15.95
- Number of holders
- 6
- Value change
- +$157,365
- Number of buys
- 5
- Number of sells
- 2
- Shares outstanding
- 115,301,000
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
6
Top holders
6
NVCR full security history
Ownership snapshot
Full 13F holder table
NovoCure Ltd SEC filings
NovoCure Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G6674U108
Recent filing periods:
Ownership snapshot
Top reported holders of NVCR - NovoCure Ltd - Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Soleus Capital Master Fun...
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.1%
13D/G row: Soleus Capital Master Fund, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Soleus Capital Master Fund, L.P. leads the comparable SEC ownership view at 9.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Soleus Capital Master Fund, L.P.'s linked filing trail.
Comparable ownership
Top 5
Soleus Capital Master Fund, L.P.
9.1%
BlackRock, Inc.
8.3%
VANGUARD PORTFOLIO MANAGEMENT LLC
5.6%
Capital World Investors
1.8%
Asaf Danziger
0.36%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. |
13D/G
|
9.1%
|
$110,694,725
10,492,391 shares
|
+$20,696,209 | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
8.3%
from 13D/G
|
$203,217,541
13,413,699 shares
|
— | 30 Jun 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Portfolio Management
|
5.6%
from 13D/G
|
$95,028,224
6,272,490 shares
|
— | 30 Jun 2026 |
| Capital World Investors |
13D/G
|
1.8%
|
$25,840,000
2,000,000 shares
|
-$56,626,396 | 30 Sep 2025 |
| Asaf Danziger |
3/4/5
Director
|
0.36%
|
$4,542,487
416,742 shares
|
— | 30 Jun 2026 |
| FMR LLC |
13F
Company
|
15%
|
$263,202,136
17,373,078 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
25,018
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
217
Q3 2026 holders
6
Holder diff
-211
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend